NASDAQ: CGNX
Cognex Corp Stock

$67.80-3.51 (-4.92%)
Updated Jul 2, 2026
CGNX Price
$67.80
Fair Value Price
$14.90
Market Cap
$11.28B
52 Week Low
$31.77
52 Week High
$72.88
P/E
79.76x
P/B
7.63x
P/S
7.82x
PEG
2.23x
Dividend Yield
0.49%
Revenue
$1.05B
Earnings
$142.54M
Gross Margin
68%
Operating Margin
20.71%
Profit Margin
13.6%
Debt to Equity
0.36
Operating Cash Flow
$250M
Beta
1.4
Next Earnings
Jul 29, 2026
Ex-Dividend
N/A
Next Dividend
N/A

CGNX Overview

Cognex Corporation specializes in machine vision technology, offering solutions that interpret and process visual data to streamline and automate production and logistics operations globally. Their advanced vision systems enable the automated manufacturing and tracking of individual components or finished goods, such as mobile devices, pharmaceutical containers, and automotive parts. This is achieved by precisely locating, recognizing, examining, and gauging items throughout their journey from production to delivery. The company provides a comprehensive software portfolio, including VisionPro, a collection of patented tools for sophisticated development; QuickBuild, an intuitive platform enabling users to create vision applications via a graphical, flowchart interface; and its specialized deep learning vision software. Beyond software, their offerings encompass robust vision sensors for tasks like ensuring component presence and accurate sizing, alongside the versatile In-Sight series of integrated vision systems and sensors. These tools support a variety of critical inspection functions, such as pinpointing part locations, confirming identities, precise dimensioning, validating assembly, and guiding robotics. Another key product is DataMan, their line of image-based barcode readers and verification systems. Cognex serves a diverse clientele across various sectors, including consumer electronics, automotive manufacturing, general consumer goods, food and beverage processing, pharmaceuticals, and medical device production. Their products are distributed directly and through a global network of partners and system integrators. Established in 1981, Cognex Corporation maintains its headquarters in Natick, Massachusetts.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine CGNX's potential to beat the market

BBuy
  • Stocks with a Zen Rating of Buy (B) had an average return of +17.17% per year. Learn More

Zen Rating Component Grades

B
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Scientific & Technical Instrument

Industry Rating
A
CGNX
Ranked
#5 of 21

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$105.54A
$313.86B
$365.56B
View Top Scientific & Technical Instrument Stocks

Be the first to know about important CGNX news, forecast changes, insider trades & much more!

CGNX News

Overview

Due Diligence Score

Industry Average (36)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CGNX scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CGNX ($67.80) is overvalued by 355.09% relative to our estimate of its Fair Value price of $14.90 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
CGNX ($67.80) is not significantly undervalued (355.09%) relative to our estimate of its Fair Value price of $14.90 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
CGNX ($67.80) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more CGNX due diligence checks available for Premium users.

Valuation

CGNX fair value

Fair Value of CGNX stock based on Discounted Cash Flow (DCF)

Price
$67.80
Fair Value
$14.90
Overvalued by
355.09%
CGNX ($67.80) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CGNX ($67.80) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CGNX ($67.80) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

CGNX price to earnings (PE)

For valuing profitable companies with steady earnings

Company
79.76x
Industry
69.86x
Market
8.55x
CGNX is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CGNX is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

CGNX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
7.63x
Industry
4.75x
CGNX is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CGNX price to earnings growth (PEG)

For valuing profitable companies with growth potential

CGNX is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

CGNX's financial health

Profit margin

Revenue
$268.4M
Net Income
$51.7M
Profit Margin
19.3%
CGNX's Earnings (EBIT) of $216.76M... subscribe to Premium to read more.
Interest Coverage Financials
CGNX's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$2.0B
Liabilities
$526.6M
Debt to equity
0.36
CGNX's short-term assets ($690.35M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CGNX's short-term assets ($690.35M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CGNX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CGNX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$45.1M
Investing
$791.0k
Financing
-$68.9M
CGNX's operating cash flow ($250.11M)... subscribe to Premium to read more.
Debt Coverage Financials

CGNX vs Scientific & Technical Instrument Stocks

TickerZen RatingMarket Cap1d %P/EP/B
CGNXB$11.28B-4.92%79.76x7.63x
TRMBB$12.36B+0.87%27.63x2.19x
ESEC$8.62B-2.09%27.89x5.44x
STB$6.59B-2.60%141.69x2.31x
NOVTB$5.76B-1.21%115.51x4.39x

Cognex Stock FAQ

What is Cognex's quote symbol?

(NASDAQ: CGNX) Cognex trades on the NASDAQ under the ticker symbol CGNX. Cognex stock quotes can also be displayed as NASDAQ: CGNX.

If you're new to stock investing, here's how to buy Cognex stock.

What is the 52 week high and low for Cognex (NASDAQ: CGNX)?

(NASDAQ: CGNX) Cognex's 52-week high was $72.88, and its 52-week low was $31.77. It is currently -6.97% from its 52-week high and 113.41% from its 52-week low.

How much is Cognex stock worth today?

(NASDAQ: CGNX) Cognex currently has 166,419,451 outstanding shares. With Cognex stock trading at $67.80 per share, the total value of Cognex stock (market capitalization) is $11.28B.

Cognex stock was originally listed at a price of $6.81 in Dec 31, 1997. If you had invested in Cognex stock at $6.81, your return over the last 28 years would have been 895.3%, for an annualized return of 8.55% (not including any dividends or dividend reinvestments).

How much is Cognex's stock price per share?

(NASDAQ: CGNX) Cognex stock price per share is $67.80 today (as of Jul 2, 2026).

What is Cognex's Market Cap?

(NASDAQ: CGNX) Cognex's market cap is $11.28B, as of Jul 3, 2026.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Cognex's market cap is calculated by multiplying CGNX's current stock price of $67.80 by CGNX's total outstanding shares of 166,419,451.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.